North America

Controversial move to waive patent protections for vaccines is a key element.

Democrats have no workable plan to tackle the cost of prescription drugs, even with full control of Washington and after campaigning on the issue for years.

California’s dentist and doctor lobbies say insurance companies are flush with cash after collecting premiums during the pandemic but paying fewer claims than usual—and should foot the bill.

Despite the industry’s lobbying efforts, the Biden administration bowed to intense pressure at home and abroad and announced support for temporarily waiving international patent protections for COVID vaccines and manufacturing technology. 

Innovators and entrepreneurs, scientists and CEOs reacted with deep concern to the Biden administration’s decision this week to support temporarily waiving intellectual property rights for COVID-19 vaccines.

There is now a broad consensus in the Democratic party that something needs to be done about drug prices. What the president has just done is show it can be done.

A federal judge warns drug manufacturers they won't be able to plea out of an 800% price hike on diabetes med. Mike Papantonio & Farron Cousins discuss more.

Special syringes are key to extracting all of the doses of Covid-19 vaccines from vials so none are wasted. There’s a U.S. shortage of them and production isn’t expected to ramp up soon.

Drug makers must face claims by purchasers that they conspired to suppress generic competition through an illegal patent settlement.

The Biden agenda has run into the hardest roadblock in health care: How do you pay for it?

Lab companies have been booking record profits by charging $100 per test.

President Joe Biden on Wednesday supported a proposal to waive World Trade Organization intellectual property (IP) rules, which would allow poorer countries to produce vaccine for themselves.

The approval process is likely to take months.

If you’re a drug manufacturer looking for patients, one company has become a major destination in the past few years: Facebook.

The QALY is a measure that attempts to capture the impact of disease — and the possible beneficial effects of treatment — on both the length and quality of life.